The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
BackgroundTo date, no effective curative option is available for children with neuroblastoma (NB) who failed tandem high‐dose chemotherapy and autologous stem cell transplantation (HDCT/autoSCT). The present study evaluated the feasibility and efficacy of reduced‐intensity allogeneic stem cell transplantation (RI alloSCT) in six children with NB who failed tandem HDCT/autoSCT.
ProcedureA cyclophosphamide/fludarabine...
Background
We performed a pilot study (NCT 00793351) to evaluate the effectiveness and feasibility of a strategy incorporating high‐dose 131I‐metaiodobenzylguanidine (HD‐MIBG) treatment into killer immunoglobulin‐like receptor (KIR)/HLA‐ligand mismatched haploidentical stem cell transplantation (haplo‐SCT) in improving the survival of children with neuroblastoma who failed previous tandem autologous...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.